These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16192516)

  • 1. The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
    Hirota K; Kudo M; Hashimoto H; Kushikata T
    Anesth Analg; 2005 Oct; 101(4):1038-1041. PubMed ID: 16192516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?
    Hashimoto H; Kushikata T; Kudo M; Hirota K
    J Gastroenterol; 2007 Apr; 42(4):275-8. PubMed ID: 17464455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a single 24-hour pre-anesthetic dose of proton pump inhibitors.
    Hirota K; Imai A; Kudo M; Hashimoto H; Kushikata T
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1244-7. PubMed ID: 19486452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular use of H2 blockers reduces the efficacy of roxatidine to control gastric pH and volume.
    Hirota K; Kudo M; Kushikata T; Hashimoto H; Matsuki A
    Can J Anaesth; 2005 Feb; 52(2):166-71. PubMed ID: 15684257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.
    Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Hishida A; Ohashi K; Ishizaki T
    Clin Pharmacol Ther; 2005 Apr; 77(4):302-11. PubMed ID: 15903128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
    Nishina K; Mikawa K; Takao Y; Shiga M; Maekawa N; Obara H
    Anesth Analg; 2000 Mar; 90(3):717-21. PubMed ID: 10702463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral rehydration therapy on gastric volume and pH in patients with preanesthetic H2 antagonist.
    Nakai K; Niwa H; Kitayama M; Satoh Y; Hirota K
    J Anesth; 2012 Dec; 26(6):936-8. PubMed ID: 22814485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings.
    Gon S; Irie Y; Takahashi M
    Jpn J Thorac Cardiovasc Surg; 2006 Jul; 54(7):278-84. PubMed ID: 16898640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
    Uesugi T; Mikawa K; Nishina K; Morikawa O; Takao Y; Obara H
    Anesth Analg; 2002 Jul; 95(1):144-7, table of contents. PubMed ID: 12088958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
    Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
    Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preanaesthetic H2 antagonists for acid aspiration pneumonia prophylaxis. Is there evidence of tolerance?
    Hirota K; Kushikata T
    Br J Anaesth; 2003 May; 90(5):576-9. PubMed ID: 12697583
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
    Bersenas AM; Mathews KA; Allen DG; Conlon PD
    Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
    Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of roxatidine acetate in fasting patients prior to induction of anaesthesia as prophylaxis against the acid aspiration syndrome.
    Tryba M; Wruck G; Thole H; Zenz M
    Drugs; 1988; 35 Suppl 3():20-4. PubMed ID: 2905245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.
    Memiş D; Turan A; Karamanlioglu B; Saral P; Türe M; Pamukçu Z
    Anesth Analg; 2003 Nov; 97(5):1360-1363. PubMed ID: 14570652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers.
    Saitoh T; Fukushima Y; Otsuka H; Hirakawa J; Mori H; Asano T; Ishikawa T; Katsube T; Ogawa K; Ohkawa S
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1811-7. PubMed ID: 12269976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.